Phosphoinositide metabolism, aging and Alzheimer's disease.
暂无分享,去创建一个
[1] J. Jolles,et al. Platelet phosphatidylinositol kinase activity is not altered in Alzheimer disease. , 1993, Molecular and chemical neuropathology.
[2] J. Jolles,et al. Brain phosphatidic acid and polyphosphoinositide formation in a broken cell preparation: Regional distribution and the effect of age , 1992, Neurochemistry International.
[3] C. Hensey,et al. The protein kinase C family. , 1992, European journal of biochemistry.
[4] P. Janmey,et al. Identification of a polyphosphoinositide-binding sequence in an actin monomer-binding domain of gelsolin. , 1992, The Journal of biological chemistry.
[5] P. Hawkins,et al. Platelet-derived growth factor stimulates synthesis of Ptdlns(3,4,5)P3 by activating a Ptdlns(4,5)P2 3-OH kinase , 1992, Nature.
[6] C. Surridge,et al. Phosphatidylinositol inhibits microtubule assembly by binding to microtubule-associated protein 2 at a single, specific, high-affinity site. , 1992, Biochemistry.
[7] B. Winblad,et al. Preservation of Gi-protein inhibited adenylyl cyclase activity in the brains of patients with Alzheimer's disease , 1992, Neuroscience Letters.
[8] E. Friedman,et al. Aging-induced decrease in dopaminergic-stimulated phosphoinositide metabolism in rat brain , 1992, Neurobiology of Aging.
[9] S. Rhee,et al. Regulation of inositol phospholipid-specific phospholipase C isozymes. , 1992, The Journal of biological chemistry.
[10] J. Jolles,et al. Phosphatidylinositol Kinase Is Reduced in Alzheimer's Disease , 1992, Journal of neurochemistry.
[11] T. Taniguchi,et al. Phosphatidylinositol-specific phospholipase C activity in the postmortem human brain: no alteration in Alzheimer's disease , 1992, Brain Research.
[12] B. Winblad,et al. Adenylyl Cyclase Activity in Postmortem Human Brain: Evidence of Altered G Protein Mediation in Alzheimer's Disease , 1992, Journal of neurochemistry.
[13] C. Advokat,et al. Excitatory amino acids and memory: Evidence from research on Alzheimer's disease and behavioral pharmacology , 1992, Neuroscience & Biobehavioral Reviews.
[14] S. Iwashita,et al. Signal transduction system for growth factor receptors associated with tyrosine kinase activity: epidermal growth factor receptor signalling and its regulation. , 1992, Cellular signalling.
[15] J. Warsh,et al. Inositol 1,4,5-trisphosphate receptor in developing and senescent rat cerebellum , 1992, Neurobiology of Aging.
[16] C. Gelbmann,et al. Chronic treatment with phosphatidylserine restores muscarinic cholinergic receptor deficits in the aged mouse brain , 1992, Neurobiology of Aging.
[17] G. Johnson,et al. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. , 1992, The Journal of biological chemistry.
[18] B. Agranoff,et al. Inositol Lipids and Signal Transduction in the Nervous System: An Update , 1992, Journal of neurochemistry.
[19] Y. Nishizuka,et al. Protein kinase C in rat brain synaptosomes , 1991, FEBS letters.
[20] B. Winblad,et al. Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease , 1991, Neuroscience Letters.
[21] R. Tanzi,et al. Molecular genetics of Alzheimer disease amyloid. , 1991, The Journal of biological chemistry.
[22] D. Hanger,et al. A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. , 1991, The Biochemical journal.
[23] J. Boonstra,et al. Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor , 1991, The Journal of cell biology.
[24] T. Taniguchi,et al. Aberrant accumulation of phospholipase C-delta in Alzheimer brains. , 1991, The American journal of pathology.
[25] B. Winblad,et al. Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain , 1991, Journal of the Neurological Sciences.
[26] E. Masliah,et al. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] H. Thaler,et al. Inositol phosphates and intracellular calcium after bradykinin stimulation in fibroblasts from young, normal aged and Alzheimer donors , 1991, Neurobiology of Aging.
[28] M. Plantavid,et al. Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. , 1991, The Journal of biological chemistry.
[29] B. Winblad,et al. Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[30] D. F. Musto,et al. Opium, cocaine and marijuana in American history. , 1991, Scientific American.
[31] J. Price,et al. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.
[32] J. Mcculloch,et al. Robustness of G Proteins in Alzheimer's Disease: An Immunoblot Study , 1991, Journal of neurochemistry.
[33] L. Cantley,et al. Novel polyphosphoinositides in cell growth and activation. , 1991, Cancer cells.
[34] L. Svennerholm,et al. Membrane Lipids in the Aging Human Brain , 1991, Journal of neurochemistry.
[35] J. Pettegrew,et al. L‐Phosphoserine, a Metabolite Elevated in Alzheimer's Disease, Interacts with Specific L‐Glutamate Receptor Subtypes , 1991, Journal of Neurochemistry.
[36] N. Cairns,et al. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. , 1991, The Biochemical journal.
[37] H. Tilson,et al. Age-dependent changes in receptor-stimulated phosphoinositide turnover in the rat hippocampus , 1991, Pharmacology Biochemistry and Behavior.
[38] E. Masliah,et al. Altered Protein Tyrosine Phosphorylation in Alzheimer's Disease , 1991, Journal of neurochemistry.
[39] G. Miner,et al. Na+/Ca2+ exchange activity is increased in Alzheimer's disease brain tissues , 1991, Brain Research.
[40] P. Galloway,et al. Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology , 1991, Brain Research.
[41] L. Hunyady,et al. Second messengers derived from inositol lipids , 1991, Journal of bioenergetics and biomembranes.
[42] G. Daley,et al. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants , 1991, Molecular and cellular biology.
[43] A. Saltiel. The role of glycosyl-phosphoinositides in hormone action , 1991, Journal of bioenergetics and biomembranes.
[44] J. Bohl,et al. Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes , 1991, Brain Research.
[45] L. Cantley,et al. Oncogenes and signal transduction , 1991, Cell.
[46] P. Wilce,et al. Effects of chronic ethanol treatment and aging on brain phosphoinositide turnover and adenylate cyclase activity , 1990, Neurochemistry International.
[47] J. Jolles,et al. Phosphatidic acid and polyphosphoinositide formation in a broken cell preparation from rat brain: Effects of different incubation conditions , 1990, Neurochemistry International.
[48] P. Majerus,et al. Pathway for the formation of D-3 phosphate containing inositol phospholipids in intact human platelets. , 1990, The Journal of biological chemistry.
[49] C. Taylor,et al. The role of G proteins in transmembrane signalling. , 1990, The Biochemical journal.
[50] L. Cantley,et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. , 1990, The Journal of biological chemistry.
[51] C. Downes,et al. myo-inositol metabolites as cellular signals. , 1990, European journal of biochemistry.
[52] M. Trabucchi,et al. Regulation of phorbol ester binding and protein kinase C activity in aged rat brain , 1990, Neurobiology of Aging.
[53] T. Koyama,et al. Membrane Viscosity Correlates with α1‐Adrenergic Signal Transduction of the Aged Rat Cerebral Cortex , 1990, Journal of neurochemistry.
[54] E. Masliah,et al. Differential involvement of protein kinase C isozymes in Alzheimer's disease , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[55] A. Tanaka,et al. Association of type I phosphatidylinositol kinase activity with mutationally activated forms of human pp60c-src , 1990, Molecular and cellular biology.
[56] T. Oltersdorf,et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.
[57] J. Pettegrew,et al. Changes in Brain Energy and Phospholipid Metabolism During Development and Aging in the Fischer 344 Rat , 1990, Journal of neuropathology and experimental neurology.
[58] D. Price,et al. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.
[59] N. Zahniser,et al. Decreased efficacy of inositol 1,4,5-trisphosphate to elicit calcium mobilization from cerebrocortical microsomes of aged rats. , 1990, Molecular pharmacology.
[60] S. Yen,et al. Alzheimer disease proteins (A68) share epitopes with tau but show distinct biochemical properties , 1990, Journal of neuroscience research.
[61] M. G. Low. The glycosyl-phosphatidylinositol anchor of membrane proteins. , 1989, Biochimica et biophysica acta.
[62] L. Dekker,et al. Inhibition of noradrenaline release by antibodies to B-50 (GAP-43) , 1989, Nature.
[63] E. El-Fakahany,et al. Aging does not alter brain muscarinic receptor-mediated phosphoinositide hydrolysis and its inhibition by phorbol esters, tetrodotoxin and receptor desensitization. , 1989, The Journal of pharmacology and experimental therapeutics.
[64] L. Cantley,et al. Polyphosphoinositides produced by phosphatidylinositol 3-kinase are poor substrates for phospholipases C from rat liver and bovine brain. , 1989, The Journal of biological chemistry.
[65] Michael J. Berridge,et al. Inositol phosphates and cell signalling , 1989, Nature.
[66] R. Parthasarathy,et al. The identification of a novel inositol lipid, phosphatidylinositol trisphosphate (PIP3), in rat cerebrum using in vivo techniques. , 1989, Biochemical and Biophysical Research Communications - BBRC.
[67] Y. Henis,et al. Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of cAMP accumulation and alters the pathway of muscarinic-stimulated phosphoinositide hydrolysis. , 1989, Biochemistry.
[68] G. Fisher,et al. Isolation and characterization of one soluble and two membrane-associated forms of phosphoinositide-specific phospholipase C from human platelets. , 1989, Biochemistry.
[69] S. Y. Lee,et al. Studies of inositol phospholipid-specific phospholipase C. , 1989, Science.
[70] P. Mulvihill,et al. Immunoaffinity demonstration that paired helical filaments of Alzheimer disease share epitopes with neurofilaments, MAP2 and tau , 1989, Brain Research.
[71] P. Libby,et al. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.
[72] R. Davis,et al. Protein kinase C inhibition of the epidermal growth factor receptor tyrosine protein kinase activity is independent of the oligomeric state of the receptor. , 1989, The Journal of biological chemistry.
[73] Kenneth S. Kosik,et al. Developmentally regulated expression of specific tau sequences , 1989, Neuron.
[74] P. Hawkins,et al. Metabolic and structural evidence for the existence of a third species of polyphosphoinositide in cells: D-phosphatidyl-myo-inositol 3-phosphate. , 1989, The Biochemical journal.
[75] E. Georges,et al. Neurofilament Phosphorylation in Cultured Bovine Adrenal Chromaffin Cells Is Stimulated by Phorbol Ester , 1989, Journal of neurochemistry.
[76] H. Hanafusa,et al. Phosphatidylinositol kinase activity associates with viral p60src protein , 1989, Molecular and cellular biology.
[77] K. Jellinger,et al. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.
[78] Hoau Yan Wang,et al. Effect of Age on Brain Cortical Protein Kinase C and Its Mediation of 5‐Hydroxytryptamine Release , 1989, Journal of neurochemistry.
[79] S. Kish,et al. Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease , 1988, Neuroscience Letters.
[80] Y. Nishizuka,et al. The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.
[81] P. Taylor,et al. An inositol tetrakisphosphate-containing phospholipid in activated neutrophils , 1988, Nature.
[82] K. Dobkins,et al. Decreased levels of protein kinase C in Alzheimer brain , 1988, Brain Research.
[83] R. Nixon,et al. Phosphorylation of neurofilament proteins by protein kinase C , 1988, FEBS letters.
[84] L. Cantley,et al. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate , 1988, Nature.
[85] G. Roth,et al. Age-related impairment in rat parotid cell alpha 1-adrenergic action at the level of inositol trisphosphate responsiveness. , 1988, Biochimica et biophysica acta.
[86] J. Baudier,et al. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. , 1987, The Journal of biological chemistry.
[87] J. Baudier,et al. Separation of the different microtubule-associated tau protein species from bovine brain and their mode II phosphorylation by Ca2+/phospholipid-dependent protein kinase C. , 1987, The Journal of biological chemistry.
[88] O. Petersen,et al. Synergism of inositol trisphosphate and tetrakisphosphate in activating Ca2+-dependent K+ channels , 1987, Nature.
[89] A. Matus,et al. Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated proteins. , 1987, Biochemistry.
[90] D. Kaplan,et al. Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation. , 1987, The Biochemical journal.
[91] S. Courtneidge,et al. An 81 kd protein complexed with middle T antigen and pp60c-src : A possible phosphatidylinositol kinase , 1987, Cell.
[92] G. Gibson,et al. Calcium and the aging nervous system , 1987, Neurobiology of Aging.
[93] J. Harris,et al. Calcium and neuronal cytoskeletal proteins: Alterations with aging , 1987, Neurobiology of Aging.
[94] G. Barritt. Intracellular free calcium and inositol polyphosphate action as potential targets in the ageing process , 1987, Neurobiology of Aging.
[95] T. Akiyama,et al. Protein kinase C phosphorylates tau and induces its functional alterations , 1987, FEBS letters.
[96] M. G. Low,et al. Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors. , 1987, The Biochemical journal.
[97] I. Litosch. Guanine nucleotide and NaF stimulation of phospholipase C activity in rat cerebral-cortical membranes. Studies on substrate specificity. , 1987, The Biochemical journal.
[98] J. Hawthorne,et al. Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.
[99] P. Coleman,et al. Dendritic extent in human dentate gyrus granule cells in normal aging and senile dementia , 1987, Brain Research.
[100] M. Berridge,et al. Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea urchin eggs by a mechanism dependent on external Ca2+. , 1986, The Biochemical journal.
[101] G. Zubenko. Hippocampal membrane alteration in Alzheimer's disease , 1986, Brain Research.
[102] J. Parente,et al. Use of fluoride ion as a probe for the guanine nucleotide‐binding protein involved in the phosphoinositide‐dependent neutrophil transduction pathway , 1986, FEBS letters.
[103] A. A. Abdel-Latif. Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. , 1986, Pharmacological reviews.
[104] P. Cuatrecasas,et al. Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase. , 1986, Science.
[105] Y. Nishizuka. Studies and perspectives of protein kinase C. , 1986, Science.
[106] A. Kowluru,et al. Secretagogue-responsive and -unresponsive pools of phosphatidylinositol in pancreatic islets. , 1986, Archives of biochemistry and biophysics.
[107] J. Smith,et al. Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells. , 1985, The Journal of biological chemistry.
[108] J. Putney,et al. Inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate formation in Ca2+-mobilizing-hormone-activated cells. , 1985, The Biochemical journal.
[109] E. Anggard,et al. Metabolism of inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate in rat parotid glands. , 1985, The Biochemical journal.
[110] L. Cantley,et al. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.
[111] E. Neufeld,et al. Phosphoinositide interconversion in thrombin-stimulated human platelets. , 1985, The Journal of biological chemistry.
[112] M. Berridge. Inositol trisphosphate and diacylglycerol as second messengers. , 1984, The Biochemical journal.
[113] Y. Nishizuka. The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.
[114] Jonathan A. Cooper,et al. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.
[115] M. Monaco,et al. Characterization of the hormone-sensitive phosphatidylinositol pool in WRK-1 cells. , 1983, The Journal of biological chemistry.
[116] M. J. Berridge,et al. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate , 1983, Nature.
[117] J. Hawthorne,et al. Free and total lipid myo-inositol concentrations decrease with age in human brain. , 1983, Biochimica et biophysica acta.
[118] M. Berridge,et al. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. , 1983, The Biochemical journal.
[119] G. Calderini,et al. Biochemical changes of rat brain membranes with aging , 1983, Neurochemical Research.
[120] E. Lapetina,et al. Rapid decrease of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. , 1982, The Journal of biological chemistry.
[121] F. Crews,et al. Age dependent changes in the methylation of rat brain phospholipids , 1981, Brain Research.
[122] P. Cuatrecasas,et al. Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets. , 1981, The Journal of biological chemistry.
[123] D. Hegner. Age-dependence of molecular and functional changes in biological membrane properties , 1980, Mechanisms of Ageing and Development.
[124] J. Putney,et al. Is phosphatidic acid a calcium ionophore under neurohumoral control? , 1980, Nature.
[125] M. Berridge,et al. Relationship between phosphatidylinositol synthesis and recovery of 5-hydroxytryptamine-responsive Ca2+ flux in blowfly salivary glands. , 1979, The Biochemical journal.
[126] A. Globerson,et al. Viscosity of lymphocyte plasma membrane in aging mice and its possible relation to serum cholesterol , 1979, Mechanisms of Ageing and Development.
[127] A. Globerson,et al. Perturbation of lymphocyte response to concanavalin A by exogenous cholesterol and lecithin , 1978 .
[128] J. Eichberg,et al. Diphosphoinositide and triphosphoinositide in animal tissues. Extraction, estimation and changes post mortem. , 1965, The Biochemical journal.
[129] L. Hokin,et al. Enzyme secretion and the incorporation of P32 into phospholipides of pancreas slices. , 1953, The Journal of biological chemistry.
[130] B. Corain. Alzheimer's disease : advances in clinical and basic research , 1993 .
[131] K. Iqbal. Alzheimer's disease : basic mechanisms, diagnosis and therapeutic strategies , 1991 .
[132] C. Salzman. Aging Brain and Dementia: New Trends in Diagnosis and Therapy , 1991 .
[133] V. Lee,et al. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[134] M. Trabucchi,et al. The aging brain: protein phosphorylation as a target of changes in neuronal function. , 1991, Life sciences.
[135] C. Downes,et al. Phosphoinositide 3-kinase: a new effector in signal transduction? , 1991, Cellular signalling.
[136] Stanley I. Rapoport,et al. Imaging, Cerebral Topography and Alzheimer’s Disease , 1990, Research and Perspectives in Alzheimer’s Disease.
[137] B. S. Alam,et al. Effect of ageing on adenylate cyclase activity and G-proteins in rat submandibular salivary glands. , 1990, Archives of oral biology.
[138] M. Berridge,et al. Inositol trisphosphate and diacylglycerol: two interacting second messengers. , 1987, Annual review of biochemistry.
[139] L. Hokin. Receptors and phosphoinositide-generated second messengers. , 1985, Annual review of biochemistry.
[140] M. Shinitzky,et al. The modulation of protein phosphorylation and receptor binding in synaptic membranes by changes in lipid fluidity: implications for ageing. , 1982, Progress in brain research.